MANNATECH INC Operating Lease, Liability, Current
MANNATECH INC (MTEX) had Operating Lease, Liability, Current of $1.58 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $1.58M.
- 2026-03-31: Operating Lease, Liability, Current $1.60M.
- 2025-12-31: Operating Lease, Liability, Current $1.67M.
- 2025-09-30: Operating Lease, Liability, Current $1.75M.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.60M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.67M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.75M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $981.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.18M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $1.51M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.68M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.69M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.66M 10-K · filed 2025-03-26 | $1.66M 10-K · filed 2024-03-28 |
| 2022-12-31 | $1.60M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $1.49M 10-K · filed 2023-03-17 | |
| 2020-12-31 | $2.07M 10-K · filed 2022-03-15 | |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.62M 10-K · filed 2021-03-19 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |